04
Stand your Ground
On Nov. 30, 2020, the US District Court for the District of Delaware on remand upheld the validity of various patents of Tris Pharma relating to Quillivant XR® (methylphenidate HCl aqueous extended release oral suspension) and found Actavis’s product infringing. Court found all the asserted patents/claims valid, and Actavis directly infringe, contributorily infringe, and induce […]